Related Experiment Video
Updated: Jun 16, 2026
12:16
Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma
Published on: March 13, 2013
Molecular evolutionary analysis of cancer cell lines
Yan Zhang1, Michael J Italia, Kurt R Auger
1Department of Biology, Pennsylvania State University, University Park, Pennsylvania, USA.
Molecular Cancer Therapeutics
|February 4, 2010
Summary
Molecular evolutionary analysis of cancer cell lines reveals shared DNA variant patterns across diverse tumor types, suggesting common oncogenic pathways. This approach aids in tumor classification and developing new anticancer strategies.
Area of Science:
- Computational biology
- Molecular evolution
- Cancer genomics
Background:
- Genome-wide cancer studies generate vast DNA sequence data, necessitating advanced computational methods to understand mutation impacts on tumor survival and proliferation.
- Molecular evolutionary analysis, highly valuable in other DNA studies, remains underutilized in cancer biology despite tumors exhibiting Darwinian evolutionary processes.
Purpose of the Study:
- To apply phylogenetic analysis to cancer cell lines to identify novel computational approaches for understanding tumor evolution.
- To explore the potential of molecular evolutionary analysis in cancer classification and the development of new therapeutic strategies.
Main Methods:
- Phylogenetic analysis of 353 cancer cell lines using multiple sequence alignments of DNA and amino acid variants from 494 and 523 genes, respectively.
- Reconstruction of phylogenetic trees to cluster cell lines based on shared DNA variant patterns.
- Statistical analysis of mRNA microarray data to compare gene expression profiles of distinct cell line clusters.
- Positive selection analysis to identify potential driver mutations.
Main Results:
- Phylogenetic trees clustered cancer cell lines by shared DNA variant patterns, not by cancer tissue type, indicating similar oncogenic pathways in tumors of diverse histologies.
- A distinct clade of 91 cancer cell lines showed significantly different gene expression profiles, suggesting functional pathway similarities reflected in DNA variant-based phylogenetic clustering.
- Positive selection analysis identified specific DNA variants as potential driver mutations.
Conclusions:
- Phylogenetic analysis of DNA variants provides a powerful tool for classifying tumors and uncovering shared oncogenic pathways across different cancer types.
- Molecular evolutionary approaches hold significant potential for developing novel anticancer strategies and improving our understanding of tumor biology.
Related Concept Videos
02:12What is Cancer?
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:29Modern Molecular Taxonomy
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...